Table 4 Ongoing phase III trials in patients with pancreatic carcinoma

Nov 19, 2014

10 likes | 160 Views

Table 4 Ongoing phase III trials in patients with pancreatic carcinoma. Stathis, A. & Moore, M. J. (2010) Advanced pancreatic carcinoma: current treatment and future challenges Nat. Rev. Clin. Oncol. doi:10.1038/nrclinonc.2009.236.

Share Presentation

Embed Code

Link

patients
pancreatic carcinoma
future challenges
1038 nrclinonc
doi 10

colleen-bernard

Download Presentation

Table 4 Ongoing phase III trials in patients with pancreatic carcinoma

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

Table 4 Ongoing phase III trials in patients with pancreatic carcinoma Stathis, A. & Moore, M. J.(2010)Advanced pancreatic carcinoma: current treatment and future challenges Nat. Rev. Clin. Oncol. doi:10.1038/nrclinonc.2009.236

stroke prevention in patients with atrial fibrillation findings from the phase ii petro trial and ongoing phase iii re

At least as efficacious as current standard therapyAt least as safe as current standard therapyAvailable for oral administrationRequire no monitoringNo relevant interactions with food and common drugsCost-effective... in order to aid treatment compliance and avoid the serious consequences of thrombosis and bleeding.

536 views • 10 slides

New Designs for Phase III Clinical Trials

New Designs for Phase III Clinical Trials. Richard Simon, D.Sc. Chief, Biometric Research Branch National Cancer Institute http://brb.nci.nih.gov. BRB Website http://brb.nci.nih.gov. Powerpoint presentations & reprints BRB-ArrayTools software

787 views • 54 slides

Ongoing PrEP Trials

204 views • 9 slides

Management of Patients with Pancreatic Disease

Management of Patients with Pancreatic Disease. Pancreatitis Nutritional Support - TPN. Phillips, R. Acute Pancreatitis – inflammation gone wild. Nursing Made Incredibly Easy! Sept/Oct 2006 www.nursingcenter.com/pdf.asp. Key Questions.

539 views • 40 slides

Pancreatic carcinoma and periampulary tumors

Pancreatic carcinoma and periampulary tumors. MH Emami Poursina Hakim Research Institute IUMS Isfahan, Iran 5.10 1392. Liver, Biliary System, and Pancreas. Pancreatic masses. Pancreatitis/cyst/ Pseudocyst Autoimmune pancreatitis(AP) Neuroendocrine Tumors Lymphoma

568 views • 25 slides

Phase I Trials

Phase I Trials. Lillian L. Siu Princess Margaret Hospital. Definition(s) of a phase I trial. First evaluation of a new cancer therapy in humans First-in-human, first-in-kind (e.g. the first compound ever evaluated in humans against a new molecular target), single-agent

624 views • 41 slides

CTEP Phase III Cancer Treatment Trials with PROs & HRQOL Endpoints

CTEP Phase III Cancer Treatment Trials with PROs & HRQOL Endpoints. CTEP Program Meeting March 18, 2009. Andrea Denicoff, RN, MS, ANP Clinical Investigations Branch, CTEP, DCTD. Purpose.

223 views • 9 slides

Table 1 Current phase III trials of autologous HSCT in SSc

Table 1 Current phase III trials of autologous HSCT in SSc. Tyndall, A. (2011) HSCT for systemic sclerosis—swallows and summers Nat. Rev. Rheumatol. doi:10.1038/nrrheum.2011.136.

132 views • 1 slides

Table 2 Unsuccessful or terminated phase III trials with anti‑VEGF pathway agents

Table 2 Unsuccessful or terminated phase III trials with anti‑VEGF pathway agents. Ebos, J. M. L. & Kerbel, R. S. (2011) Antiangiogenic therapy: impact on invasion, disease progression, and metastasis Nat. Rev. Clin. Oncol. doi:10.1038/nrclinonc.2011.21.

146 views • 1 slides

Table 4 Selected trials of antihypertensive treatment in elderly patients

Table 4 Selected trials of antihypertensive treatment in elderly patients. Fleg, J. L. et al . (2010) Cardiovascular drug therapy in the elderly: benefits and challenges Nat. Rev. Cardiol. doi:10.1038/nrcardio.2010.162.

156 views • 1 slides

Table 1 Phase III trials with a survival benefit in metastatic CRPC

Table 1 Phase III trials with a survival benefit in metastatic CRPC. Sartor, O. & Pal, S. K. ( 2012) Abiraterone and its place in the treatment of metastatic CRPC Nat. Rev. Clin. Oncol. doi:10.1038/nrclinonc.2012.202.

128 views • 1 slides

Table 1 Planned or ongoing clinical trials of radioembolization in patients with mCRC

Table 1 Planned or ongoing clinical trials of radioembolization in patients with mCRC. Nicolay, N. H. et al. (2009) Liver metastases from colorectal cancer: radioembolization with systemic therapy Nat. Rev. Clin. Oncol. doi:10.1038/nrclinonc.2009.165.

159 views • 1 slides

Palliative Care for Inoperable pancreatic carcinoma

Palliative Care for Inoperable pancreatic carcinoma. Epidemiology. Incidence in Hong Kong 1 3.7- 4.8 / 100,000 Death to incidence ratio 0.99 5 year survival rate for all stages 5%. Sohn, et al. J Am Coll Surg 1999; 188:658. 1. WHO. IARC CI5 VIII 1993-97. Who should be palliated?.

459 views • 28 slides

Traumatic Pancreatic Injury in paediatric patients

Traumatic Pancreatic Injury in paediatric patients. Joint Hospital Surgical Grand Round Oct 2013. Dr WB Wong Tuen Mun Hospital. Epidemiology. http://www.cobywootenlaw.com/bicycle-accidents/. 4th most common solid organ injury following spleen, liver and kidneys

849 views • 35 slides

Table 3 Ongoing clinical trials that study CTCs in breast cancer with therapeutic intervention

Table 3 Ongoing clinical trials that study CTCs in breast cancer with therapeutic intervention. De Mattos-Arruda, L. et al. ( 2013) Circulating tumour cells and cell-free DNA as tools for managing breast cancer Nat. Rev. Clin. Oncol. doi:10.1038/nrclinonc.2013.80.

163 views • 1 slides

Ongoing Trials in Managing Myocardial Ischemia

Ongoing Trials in Managing Myocardial Ischemia. MERLIN-TIMI 36: Study design. M etabolic E fficiency with R anolazine for L ess I schemia in N on-ST elevation acute coronary syndrome – T hrombolysis I n M yocardial I nfarction 36.

278 views • 10 slides

Phase III CVI Part 4

Phase III CVI Part 4. More Ideas. Orientation & Mobility. What is orientation? It is the ability to know where you are in space. This includes the knowledge of where you are in relation to objects, in relation to ones self, and where one object is in relation to another object.

362 views • 25 slides

Clinical Trials in Patients with Resected Stage IIB and III Melanoma

Clinical Trials in Patients with Resected Stage IIB and III Melanoma. Craig L. Slingluff, Jr., M.D. Professor of Surgery, University of Virginia Director, Human Immune Therapy Center, UVA Co-chair, Melanoma Committee, ECOG Vice-chair, Melanoma Committee, ACOSOG

249 views • 8 slides

Table 2 Ongoing clinical trials of active amyloid‑β immunotherapies

Table 2 Ongoing clinical trials of active amyloid‑β immunotherapies. Lemere, C. A. & Masliah, E. (2010) Can Alzheimer disease be prevented by amyloid‑β immunotherapy? Nat. Rev. Neurol. doi:10.1038/nrneurol.2009.219.

121 views • 1 slides

Table 1 Ongoing clinical trials of passive Aβ immunotherapies

Table 1 Ongoing clinical trials of passive Aβ immunotherapies. Lemere, C. A. & Masliah, E. (2010) Can Alzheimer disease be prevented by amyloid‑β immunotherapy? Nat. Rev. Neurol. doi:10.1038/nrneurol.2009.219.

125 views • 1 slides

Table 3 Phase III trials of targeted agents in advanced pancreatic carcinoma

Table 3 Phase III trials of targeted agents in advanced pancreatic carcinoma. Stathis, A. & Moore, M. J. (2010) Advanced pancreatic carcinoma: current treatment and future challenges Nat. Rev. Clin. Oncol. doi:10.1038/nrclinonc.2009.236.

171 views • 1 slides

Figure 3 Analysis strategies with biomarker-stratified phase III clinical trials

Figure 3 Analysis strategies with biomarker-stratified phase III clinical trials. Freidlin, B. & Korn, E. L. ( 2013) Biomarker enrichment strategies: matching trial design to biomarker credentials Nat. Rev. Clin. Oncol. doi:10.1038/nrclinonc.2013.218.

117 views • 1 slides

More Related

Table 4 Ongoing phase III trials in patients with pancreatic carcinoma

Table 4 Ongoing phase III trials in patients with pancreatic carcinoma

Presentation Transcript

stroke prevention in patients with atrial fibrillation findings from the phase ii petro trial and ongoing phase iii re

New Designs for Phase III Clinical Trials

Ongoing PrEP Trials

Management of Patients with Pancreatic Disease

Pancreatic carcinoma and periampulary tumors

Phase I Trials

CTEP Phase III Cancer Treatment Trials with PROs &amp; HRQOL Endpoints

Table 1 Current phase III trials of autologous HSCT in SSc

Table 2 Unsuccessful or terminated phase III trials with anti‑VEGF pathway agents

Table 4 Selected trials of antihypertensive treatment in elderly patients

Table 1 Phase III trials with a survival benefit in metastatic CRPC

Table 1 Planned or ongoing clinical trials of radioembolization in patients with mCRC

Palliative Care for Inoperable pancreatic carcinoma

Traumatic Pancreatic Injury in paediatric patients

Table 3 Ongoing clinical trials that study CTCs in breast cancer with therapeutic intervention

Ongoing Trials in Managing Myocardial Ischemia

Phase III CVI Part 4

Clinical Trials in Patients with Resected Stage IIB and III Melanoma

Table 2 Ongoing clinical trials of active amyloid‑β immunotherapies

Table 1 Ongoing clinical trials of passive Aβ immunotherapies

Table 3 Phase III trials of targeted agents in advanced pancreatic carcinoma

Figure 3 Analysis strategies with biomarker-stratified phase III clinical trials

CTEP Phase III Cancer Treatment Trials with PROs & HRQOL Endpoints